Diana Olusanmi is one of MaRS 21 Canadian tech entrepreneurs to watch in 2021

January 8, 2021

Diana Olusanmi moves the needle on fertility options

Despite all the developments made in reproductive science since the first “test tube” baby was born in 1978, there was still no test available to gauge the quality of a human egg. So Future Fertility, led by Diana Olusanmi, set out to change that. Her company offers AI-driven software that can calculate the health and reproductive likelihood of a human egg based on a 2D image. “There is a strong demand for greater transparency,” says Olusanmi. Since launching its first product this September, Future Fertility has heard from fertility clinics from all over the EU, Brazil, Malaysia and Japan.

What’s next: Future Fertility’s top priority for 2021 is to further refine the product and increase accuracy, which is currently 20 percent better than embryologists at predicting the likelihood of an egg becoming an embryo. The company is planning to close a Series A funding round in the first quarter of next year.

> See the article

Related posts

January 08, 2021

Women May Soon Start Using AI to Tell Good Eggs From Bad

Future Fertility, the first company to use artificial intelligence to grade the viability of women’s harvested eggs for use in [...]
April 30, 2019

Future Fertility Launches First AI Image Analysis Tool to Evaluate Women’s Eggs

TORONTO, April 30, 2019 /CNW/ — Future Fertility Inc, an AI biotech startup focusing on reproductive innovation has developed a non-invasive image [...]
March 18, 2019

How California Became the World’s Fertility Treatment Destination

In the serene, sunlight-filled waiting room of California Fertility Partners in Los Angeles—one of the world’s leading practitioners of in-vitro [...]